Nimodipine Patent Expiration
Nimodipine is used for improving neurological outcomes and reducing ischemic deficits in adult patients with subarachnoid hemorrhage from ruptured intracranial berry aneurysms. It was first introduced by Bayer Pharmaceuticals Corp
Nimodipine Patents
Given below is the list of patents protecting Nimodipine, along with the drug name that holds that patent and the company name owning that drug.
| Drug Used in | Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Drug Owner |
|---|---|---|---|---|
| Nymalize | US10342787 | Non-aqueous liquid nimodipine compositions | Apr 16, 2038 | Azurity |
| Nymalize | US10576070 | Non-aqueous liquid nimodipine compositions | Apr 16, 2038 | Azurity |
| Nymalize | US11207306 | Non-aqueous liquid nimodipine compositions | Apr 16, 2038 | Azurity |
| Nymalize | US11413277 | Non-aqueous liquid nimodipine compositions | Apr 16, 2038 | Azurity |
| Nymalize | US11517563 | Liquid nimodipine compositions | Apr 16, 2038 | Azurity |
| Nymalize | US11759457 | Liquid nimodipine compositions | Apr 16, 2038 | Azurity |
| Nymalize | US11806338 | Non-aqueous liquid nimodipine compositions | Apr 16, 2038 | Azurity |
| Nymalize | US12186308 | Non-aqueous liquid nimodipine compositions | Apr 16, 2038 | Azurity |
| Nymalize | US8517997 | Dispenser for medicaments and method and apparatus for making same |
May 14, 2024
(Expired) | Azurity |
| Nymalize | US7070581 | Dispenser for medicaments and method and apparatus for making same |
Jun 23, 2023
(Expired) | Azurity |
Nimodipine's Family Patents
Explore Our Curated Drug Screens
Drugs Generating Over $1 Billion in Annual Revenue
Explore the top-performing drugs that dominate the pharmaceutical industry
View List
NCE-1 Patent Expiry in the Next 1 Year
Identify opportunities as new chemical entity (NCE-1) patents approach expiry
View List
Recently Granted Patents in EP
Find the opportunity to file Oppositions
View List